246 related articles for article (PubMed ID: 11222883)
1. Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole.
Yamamoto K; Tamura T; Imai R; Yamamoto M
Toxicol Sci; 2001 Mar; 60(1):165-76. PubMed ID: 11222883
[TBL] [Abstract][Full Text] [Related]
2. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia.
Weissenburger J; Nesterenko VV; Antzelevitch C
J Cardiovasc Electrophysiol; 2000 Mar; 11(3):290-304. PubMed ID: 10749352
[TBL] [Abstract][Full Text] [Related]
3. Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig.
Guns PJ; Johnson DM; Weltens E; Lissens J
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):125-34. PubMed ID: 22516473
[TBL] [Abstract][Full Text] [Related]
4. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
[TBL] [Abstract][Full Text] [Related]
5. Anesthesia and arrhythmogenesis in the chronic atrioventricular block dog model.
Dunnink A; Sharif S; Oosterhoff P; Winckels S; Montagne D; Beekman J; van der Nagel R; van der Heyden MA; Vos MA
J Cardiovasc Pharmacol; 2010 Jun; 55(6):601-8. PubMed ID: 20555233
[TBL] [Abstract][Full Text] [Related]
6. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
[TBL] [Abstract][Full Text] [Related]
7. Effects of halothane and quinidine on intracardiac conduction and QTc interval in pentobarbital-anesthetized dogs.
Gallagher JD
Anesth Analg; 1992 Nov; 75(5):688-95. PubMed ID: 1416119
[TBL] [Abstract][Full Text] [Related]
8. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
van Opstal JM; Schoenmakers M; Verduyn SC; de Groot SH; Leunissen JD; van Der Hulst FF; Molenschot MM; Wellens HJ; Vos MA
Circulation; 2001 Nov; 104(22):2722-7. PubMed ID: 11723026
[TBL] [Abstract][Full Text] [Related]
9. Combination of sotalol and quinidine in a canine model of torsades de pointes: no increase in the QT-related proarrhythmic action of sotalol.
Chézalviel-Guilbert F; Deplanne V; Davy JM; Poirier JM; Xia YZ; Cheymol G; Weissenburger J
J Cardiovasc Electrophysiol; 1998 May; 9(5):498-507. PubMed ID: 9607458
[TBL] [Abstract][Full Text] [Related]
10. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.
Shimizu W; McMahon B; Antzelevitch C
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):154-64. PubMed ID: 10090218
[TBL] [Abstract][Full Text] [Related]
11. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
12. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
[TBL] [Abstract][Full Text] [Related]
13. No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block.
Thomsen MB; Beekman JD; Attevelt NJ; Takahara A; Sugiyama A; Chiba K; Vos MA
Br J Pharmacol; 2006 Dec; 149(8):1039-48. PubMed ID: 17088870
[TBL] [Abstract][Full Text] [Related]
14. Torsade de pointes and sudden death induced by thiopental and isoflurane anesthesia in dogs with cardiac electrical remodeling.
Zhou S; Cao JM; Ohara T; KenKnight BH; Chen LS; Karagueuzian HS; Chen PS
J Cardiovasc Pharmacol Ther; 2002 Jan; 7(1):39-43. PubMed ID: 12000977
[TBL] [Abstract][Full Text] [Related]
15. In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome.
Chiba K; Sugiyama A; Hagiwara T; Takahashi S; Takasuna K; Hashimoto K
Eur J Pharmacol; 2004 Feb; 486(2):189-200. PubMed ID: 14975708
[TBL] [Abstract][Full Text] [Related]
16. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.
Lu HR; Remeysen P; De Clerck F
J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372
[TBL] [Abstract][Full Text] [Related]
17. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.
Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA
J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced QT prolongation: Concordance of preclinical anesthetized canine model in relation to published clinical observations for ten CiPA drugs.
Koshman YE; Wilsey AS; Bird BM; Endemann AL; Sadilek S; Treadway J; Martin RL; Polakowski JS; Gintant GA; Mittelstadt SW
J Pharmacol Toxicol Methods; 2020; 103():106871. PubMed ID: 32360993
[TBL] [Abstract][Full Text] [Related]
19. The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.
Stams TR; Bourgonje VJ; Beekman HD; Schoenmakers M; van der Nagel R; Oosterhoff P; van Opstal JM; Vos MA
Br J Pharmacol; 2014 Feb; 171(3):714-22. PubMed ID: 24490860
[TBL] [Abstract][Full Text] [Related]
20. Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts.
Sugiyama A
Br J Pharmacol; 2008 Aug; 154(7):1528-37. PubMed ID: 18552873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
